Compare stocks

Sandoz Group AG operates in the pharmaceutical industry and is primarily focused on the development, production, and marketing of generic pharmaceuticals and biosimilars. The company offers a wide range of products including antibiotics, dermatology treatments, and respiratory medicines. Sandoz initially began as an independent company and has a notable history as part of the larger Novartis group, from which it separated to re-establish its standalone position. Headquartered in Basel, Switzerland, Sandoz has a significant global presence in various key markets. The company's strategic positioning is bolstered by its extensive portfolio of generic and biosimilar medicines, allowing it to compete effectively within the cost-sensitive segments of the pharmaceutical market.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.